Early prediction of long hospital stay for Intensive Care units readmission patients using medication information

利用用药信息早期预测重症监护室再入院患者的长期住院情况

阅读:1

Abstract

OBJECTIVE: Predicting Intensive Care Unit (ICU) Length of Stay (LOS) accurately can improve patient wellness, hospital operations, and the health system's financial status. This study focuses on predicting the prolonged ICU LOS (≥3 days) of the 2nd admission, utilizing short historical data (1st admission only) for early-stage prediction, as well as incorporating medication information. MATERIALS AND METHODS: We selected 18,572 ICU patients' records from the MIMIC-IV database for this study. We applied five machine learning classifiers: Logistic regression (LR), Random Forest (RF), Support Vector Machine (SVM), AdaBoost (AB) and XGBoost (XGB). We computed both the sum dose and the average dose for the medication and included them in our model. RESULTS: The performance of the RF model demonstrates the highest level of accuracy compared to other models, as indicated by an Area Under the Receiver Operating Characteristic Curve (AUC) of 0.716 and an Expected Calibration Error (ECE) of 0.023. DISCUSSION: The calibration improved all five classifiers (LR, RF, SVC, AB, XGB) in terms of ECE. The most important two features for RF are the length of 1st admission and the patient's age when they visited the hospital. The most important medication features are Phytonadione and Metoprolol Succinate XL. Also, both the sum and the average dose for the medication features contributed to the prediction task. CONCLUSION: Our model showed the capability to predict the prolonged ICU LOS of the 2nd admission by utilizing the demographic, diagnosis, and medication information from the 1st admission. This method can potentially support the prevention of patient complications and enhance resource allocation in hospitals.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。